A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature. Issue 5 (May 2018)

• Record Type: Journal Article
• Authors: Yamazaki, Tomoo; Joshita, Satoru; Kasuga, Eriko; Horiuchi, Kazuki; Sugiura, Ayumi; Fujimori, Naoyuki; Komatsu, Michiharu; Umemura, Takeji; Matsumoto, Akihiro; Tanaka, Eiji
• Is Part Of: Journal of infection and chemotherapy. Volume 24:Issue 5(2018:May)
• Page Start: 393
• Page End: 397
• Publication Date: 2018-05
• Subjects: Liver abscess -- Desulfovibrio desulfuricans -- Co-infection; Chemotherapy -- Periodicals; Infection -- Periodicals; Communicable diseases -- Chemotherapy -- Periodicals; 615.5805
• DOI: 10.1016/j.jiac.2017.11.006
• Languages: English
• ISSNs: 1341-321X

Abstract

Abstract: A 73-year-old woman was admitted with consciousness disturbance following a fever. Abdominal computed tomography revealed a large liver abscess with which the presence of Desulfovibrio desulfuricans and Escherichia coli was confirmed by thorough blood and abscess content culture. Empiric meropenem treatment was switched to cefoperazone/sulbactam, followed by ampicillin/sulbactam based on susceptibility testing. Desulfovibrio desulfuricans is a common bacterium that rarely causes liver abscess and may be overlooked during co-infection due to overgrowth of the accompanying bacteria. Clinicians should bear Desulfovibrio desulfuricans in mind and select the appropriate antibiotics according to susceptibility testing when anaerobic bacteria are detected in a liver abscess.